BerGenBio ASA (BRRGF) Financial Statements

BerGenBio ASA's market cap is currently $21.86M. The company's EPS TTM is $; its P/E ratio is -0.10; BerGenBio ASA is scheduled to report earnings on November 19, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.